FIRST AMERICAN HEALTH CONCEPTS INC
10QSB, 1999-12-15
BUSINESS SERVICES, NEC
Previous: ARXA INTERNATIONAL ENERGY INC, 8-K, 1999-12-15
Next: COMPUSONICS VIDEO CORP, 10-Q, 1999-12-15



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X] Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act
    of 1934. For the quarter ended October 31, 1999.

[ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act
    of 1934. For the transition period from N/A to N/A .

    Commission File Number: 0-15207


                      FIRST AMERICAN HEALTH CONCEPTS, INC.
              (Exact name of small business issuer in its charter)

        Arizona                                                86-0418406
(State of Incorporation)                                      (IRS Employer
                                                          Identification Number)

7776 South Pointe Parkway West, Suite 150, Phoenix, Arizona       85044-5424
          (Address of principal executive offices)                (Zip Code)

                                 (602) 414-0300
                (Issuer's telephone number, including area code)


           Securities Registered Pursuant to Section 12(b) of the Act:

                                      NONE

           Securities Registered Pursuant to Section 12(g) of the Act:

                         Common Stock without par value
                                (Title of class)


Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act  during the past 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing requirements for the past 90 days.

                                 Yes [X] No [ ]

Registrant's  common stock  outstanding at December 1, 1999 was 2,604,736 shares
after deducting 468,102 shares of treasury stock.
<PAGE>
                      FIRST AMERICAN HEALTH CONCEPTS, INC.

                                   FORM 10-QSB
                              FOR THE QUARTER ENDED
                                OCTOBER 31, 1999



                                TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION                                               Page
                                                                            ----
Item 1.  Financial Statements (Unaudited)

         Balance Sheet as of October 31, 1999 ............................   3

         Statement of Operations for the quarter
           ended October 31, 1999 and 1998................................   4

         Statement of Cash Flows for the three months
           ended October 31, 1999 and 1998................................   5

Notes to the Financial Statements.........................................   6

Item 2.  Management's Discussion and Analysis.............................   7


PART II.  OTHER INFORMATION

Item 4.  Submission of Matters to a Vote of Security Holders..............   9

Item 6.  Exhibits and Reports on Form 8-K.................................   9

SIGNATURES................................................................   9


                                                                          Page 2
<PAGE>
FIRST AMERICAN HEALTH CONCEPTS, Inc. and SUBSIDIARIES
CONSOLIDATED BALANCE SHEET (Unaudited)

ASSETS                                                                10/31/99
                                                                      --------
Current Assets:
     Cash and cash equivalents                                       $1,553,810
     Marketable investment securities                                   229,500
     Member fees receivable, net of allowance for
        doubtful accounts of $40,385                                  2,064,782
     Deferred expenses                                                  310,454
     Prepaid expenses                                                   159,215
     Income tax receivable                                              308,813
     Other Current Assets                                               109,748
                                                                     ----------
          Total Current Assets                                       $4,736,322

Property and Equipment:
     Office furniture and fixtures                                   $  318,986
     Office equipment                                                 3,592,262
     Leasehold improvements                                             201,083
                                                                     ----------
                                                                      4,112,331
     Less accumulated depreciation and amortization                  (2,436,861)
                                                                     ----------
          Net Property and Equipment                                  1,675,470

          Total Assets                                               $6,411,792
                                                                     ==========
LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:
     Accounts payable                                                $   38,908
     Current portion of bank loan (Note 2)                               21,100
     Deferred revenue                                                   502,374
     Accrued expenses and other current liabilities                     118,939
     Deferred income taxes                                              340,827
                                                                     ----------
          Total Current Liabilities                                   1,022,148

Shareholders' Equity:
     Common stock, no par value; Authorized
        8,000,000 shares; Issued, 3,072,838 shares                      757,296
     Additional paid-in capital                                       2,565,067
     Net unrealized loss on marketable investment securities            (21,272)
     Unearned ESOP shares (Note 2)                                      (20,035)
     Retained earnings                                                3,594,320
                                                                     ----------
                                                                      6,875,376

     Treasury stock, at cost, 468,102 shares                         (1,485,732)
                                                                     ----------
          Total Shareholders' Equity                                  5,389,644

          Total Liabilities and Shareholders' Equity                 $6,411,792
                                                                     ==========

                See notes to the financial statements (unaudited)

                                                                          Page 3
<PAGE>
FIRST AMERICAN HEALTH CONCEPTS, Inc. and SUBSIDIARIES
CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited)

                                                     Quarter ended October 31,
                                                        1999           1998
                                                     -----------    -----------
Fee revenues                                         $ 1,769,965    $ 1,617,433
Premiums assumed                                         818,173        218,825
                                                     -----------    -----------
      Total                                            2,588,138      1,836,258

Operating Expenses:
  Sales and marketing costs                              314,041        351,096
  Direct membership costs                                638,442        659,845
  General and administration                             651,244        657,319
  Assumed losses incurred and fees                       629,014        153,088
  ESOP charges                                             2,525         14,125
  Depreciation                                           135,972        134,559
                                                     -----------    -----------
      Total Operating Expenses                         2,371,238      1,970,032
                                                     -----------    -----------

      Operating Income/(Loss)                            216,900       (133,774)

Non-operating Income (Expense):
  Interest income                                         27,451         79,273
  Interest expense                                          (448)        (2,532)
                                                     -----------    -----------
      Total Non-operating Income                          27,003         76,741

      Income/(Loss) Before Income Taxes                  243,903        (57,033)

Income Taxes/(Benefit)                                    89,802        (17,109)
                                                     -----------    -----------
    Net Income/(Loss) Before Change in
     Accounting Principle                            $   154,101    $   (39,924)
                                                     ===========    ===========
Cumulative Effect of Change in Accounting
 Principle, Net of Tax                               $  (727,259)   $        --

    Net (Loss) After Change in Accounting Principle  $  (573,158)   $   (39,924)

Net Income/(Loss) Per Share - Basic Before Change
 in Accounting Principle                             $      0.06    $     (0.02)
                                                     ===========    ===========
Cumulative Effect of Change in Accounting Principle,
 Net of Tax - Basic                                  $     (0.28)   $        --
                                                     ===========    ===========
Net Income/(Loss) Per Share - Basic After Change in
 Accounting Principle                                $     (0.22)   $     (0.02)
                                                     ===========    ===========
Net Income/(Loss) Per Share - Diluted Before Change
 in Accounting Principle                             $      0.06    $     (0.02)
                                                     ===========    ===========
Cumulative Effect of Change in Accounting Principle,
 Net of Tax - Diluted                                $     (0.28)   $        --
                                                     ===========    ===========
Net Income/(Loss) Per Share - Diluted After Change
 in Accounting Principle                             $     (0.22)   $     (0.02)
                                                     ===========    ===========
Weighted Average Shares Outstanding - Basic            2,604,736      2,578,069
                                                     ===========    ===========
Weighted Average Shares Outstanding - Diluted          2,621,250      2,578,069
                                                     ===========    ===========

                See notes to the financial statements (unaudited)

                                                                          Page 4
<PAGE>
FIRST AMERICAN HEALTH CONCEPTS, Inc. and SUBSIDIARIES
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

                                                  Three months ended October 31,
                                                  ------------------------------
                                                      1999              1998
                                                  -----------       -----------
Cash Flows from Operating Activities:
  Net (loss)/income                               $  (573,158)      $   (39,924)
  Adjustments to reconcile net (loss)/income
   to net cash used in operating activities:
    Depreciation                                      135,972           134,559
    ESOP shares committed to be released                2,525            14,125
    Provision for losses on accounts receivable         2,515                --
    (Decrease) in deferred taxes                     (408,145)               --
  Increase (decrease) in cash resulting from
    changes in:
    Member fees receivable                            339,812          (271,047)
    Deferred expenses                                 988,708            97,060
    Prepaid expenses and other current assets          56,753           415,642
    Income tax receivable                              74,076           (16,949)
    Accounts payable                                  (22,018)           19,734
    Deferred revenue                                 (599,264)         (697,069)
    Accrued expenses and other current liabilities    (49,509)          (48,886)

                                                  -----------       -----------
       Net Cash (Used In) Operating Activities        (51,733)         (392,755)
                                                  -----------       -----------

Cash Flows from Investing Activities:
  Decrease in marketable investment securities             --           370,077
  Decrease in note receivable-officer                  28,794            18,048
  Purchases of property and equipment                 (49,125)         (220,988)

                                                  -----------       -----------
       Net Cash (Used In) Provided By Investing
         Activities                                   (20,331)          167,137
                                                  -----------       -----------

Cash Flows from Financing Activities:
  Proceeds from stock options exercised                    --            76,250
  Repayments of bank loan                                  --           (21,100)
  Repayments of capital lease obligation                   --            (5,330)

                                                  -----------       -----------
       Net Cash Provided By Financing Activities           --            49,820
                                                  -----------       -----------

       Net Decrease in Cash and Cash Equivalents      (72,064)         (175,798)

  Cash and Cash Equivalents, Beginning of Period    1,625,874         1,342,759
                                                  -----------       -----------
  Cash and Cash Equivalents, End of Period        $ 1,553,810       $ 1,166,961
                                                  ===========       ===========

Supplemental Disclosures of Non-Cash Activities:
     Unrealized (loss) gain on marketable
       investment securities                      $   (10,375)      $     1,738
                                                  ===========       ===========

                See notes to the financial statements (unaudited)

                                                                          Page 5
<PAGE>
                      FIRST AMERICAN HEALTH CONCEPTS, INC.

                        NOTES TO THE FINANCIAL STATEMENTS
                                   (UNAUDITED)

NOTE 1 - GENERAL

These financial statements have been prepared by First American Health Concepts,
Inc. (the Company)  without audit,  pursuant to the rules and regulations of the
Securities and Exchange Commission. In the opinion of the Company, the unaudited
financial  statements  include  all  adjustments   (consisting  only  of  normal
recurring  adjustments)  necessary to present fairly the financial position, the
results of operations, and statement of cash flows for the periods presented.

The unaudited  financial  statements  presented  herein were prepared  using the
underlying   accounting  principles  utilized  in  the  Company's  1999  audited
financial  statements,  filed on Form 10-KSB with the  Securities  and  Exchange
Commission  on October 29,  1999.  Operating  results for the three months ended
October  31, 1999 are not  necessarily  indicative  of the  results  that may be
expected for the year ending July 31, 2000.

NOTE 2 - EMPLOYEE STOCK OWNERSHIP PLAN

During fiscal 1994, the Company  implemented  an employee  stock  ownership plan
(First American Health Concepts,  Inc. Employee Stock Ownership Plan and related
Trust),  qualified  as a stock bonus plan under  Section  401(a) of the Internal
Revenue  Code.  The Plan is  designed  to  invest  primarily  in  Company  stock
exclusively for the benefit of eligible employees of the Company.  Each eligible
employee  becomes  a  participant  in the Plan  upon  completion  of one year of
service as defined by the Plan.  Company  contributions are determined each year
by the Company's  Board of Directors  (subject to certain  limitations)  and are
allocated  among the accounts of the  participants  in proportion to their total
compensation.

In October  1994,  the Trust  borrowed  $422,000  from a bank for a term of five
years  at an  annual  interest  rate of  8.42%.  The  proceeds,  along  with the
Company's 1994 ESOP  contribution,  were used to purchase 91,978 treasury shares
from the  Company.  Because  the  Company has  guaranteed  the bank loan,  it is
reported as long term debt of the Company. The shares sold by the Company to the
Trust are reflected in shareholders'  equity, and an amount corresponding to the
borrowing  (the  guaranteed  ESOP  obligation)  is reported  as a  reduction  of
shareholders' equity.

The loan agreement requires quarterly payments of principal and interest,  which
will be paid from the  Company's  contributions  to the ESOP.  As the  principal
amount of the  borrowing  is  repaid,  the  liability  and the  guaranteed  ESOP
obligation are reduced. The Company recognizes compensation expense equal to the
average fair market value of the shares  committed to be released for allocation
to participants in the ESOP, which is based on total debt service requirements.

The minimum  remaining  principal  payment required to be made during the fiscal
year ending July 31, 2000 is $21,100.

                                                                          Page 6
<PAGE>
MANAGEMENT'S DISCUSSION AND ANALYSIS

FORWARD-LOOKING STATEMENTS

This  Report  on Form  10-QSB  contains  forward-looking  statements.  The words
"believe,"  "expect,"  "anticipate,"  and  "project,"  and  similar  expressions
identify  forward-looking  statements,  which  speak  only  as of the  date  the
statement was made.  Such  forward-looking  statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections  of  revenues,  income,  or loss,
capital expenditures, plans for future operations, financing needs or plans, the
impact of inflation and plans relating to the foregoing.

RESULTS OF OPERATIONS

Operating  revenues  for the quarter  ended  October  31,  1999 were  $2,588,000
compared to  $1,836,000  for the quarter  ended October 31, 1998, an increase of
over 41%. Revenues generated from the Company's indemnity plans increased 90% to
$1,325,000  for the first  quarter  2000,  as compared to $699,000  for the same
period in the prior year.  The Company's  reinsurance  captive,  First  American
Reinsurance  Company (FARC),  revised its quota share agreement with the primary
insurance carrier in July 1999. FARC now reinsures all insured business.  During
the quarter ended October 31, 1998, FARC only reinsured business written January
1998 and later.  This contract change represents  $183,000 of the increase.  The
remaining  $443,000 increase is due to the sale of new business.  Revenue's from
the Company's  traditional  vision care savings product remained  unchanged,  at
$1,020,000,  from the same three-month period in fiscal 1999. Management expects
revenues from indemnity  plans to continue to increase in the second quarter due
to the significant number of calendar year benefit plans.  Non-insured  revenues
from the vision  care  savings  product  are  expected  to remain  flat due to a
decreasing demand for this product.

Total operating expenses increased 20% for the quarter ended October 31, 1999 to
$2,369,000.  However,  the ratio of total  operating  expenses to total  revenue
decreased to 92%, as compared to 107% for the same period in the prior year. The
increased expenses result from increased reinsurance expenses corresponding with
the increase in reinsurance premium revenue.

Sales and  marketing  costs  decreased  11% to $314,000  for the  quarter  ended
October 31,  1999,  as compared to $351,000  for the quarter  ended  October 31,
1998. The decrease is due, in part, to a timing issue related to travel expense.
The remaining  difference is related to certain  reclassification of expense. As
discussed  above,  FARC  changed the terms of its quota share  agreement in July
1999.  Therefore,  some broker-related  expenses that were previously related to
fee  income  and  charged to sales and  marketing,  have now become  reinsurance
expenses.

Direct  membership  costs,  those costs  associated  with supplying  vision plan
members with membership  materials,  maintaining a national locator service, and
administering  claims processing functions decreased to $638,000 for the quarter
ended  October 31,  1999,  as compared to $660,000 for the same period in fiscal
1999.  These expenses  decreased,  despite  increased  enrollment,  as operating
efficiencies  are achieved  through  utilization of the managed care information
system.

General and administration  expenses totaled $651,000 for the three months ended
October 31, 1999, as compared to $657,000 for the same period in the prior year.

Reinsurance  expense  increased  to $629,000 for the quarter  ended  October 31,
1999,  as compared  to $153,000  for the quarter  ended  October 31,  1998.  The
increased  expense  corresponds  to the  increase in  reinsurance  revenues.  As
discussed  above,  the  increase  is due to  increased  sales and a revision  of
contract terms.

                                                                          Page 7
<PAGE>
Depreciation  was  $136,000 for the three  months  ended  October 31,  1999,  as
compared to $135,000 for the corresponding period in the prior year.

ESOP compensation expense represents  contributions committed for the periods in
accordance with the Company's  employee stock ownership plan implemented  during
fiscal 1994. Expense recognized is affected by compensation  expense of eligible
participating  employees and the average  market price of the  Company's  common
stock during the quarter.

Interest income was $27,000 for three months ended October 31, 1999, as compared
to $79,000 for the  corresponding  period in 1998.  Interest  income  during the
quarter  ended  October  31,  1998  included  a  one-time  gain on the  sale and
reinvestment of securities.

Interest expense decreased slightly for the quarter to quarter  comparison.  The
decrease is a result of repayments  of  borrowings by the ESOP trust,  which are
guaranteed and therefore  recorded by the Company.  The ESOP commitment was paid
in full in November 1999.

LIQUIDITY AND CAPITAL RESOURCES

Working capital was $3,714,000 and the current ratio was 4.6 to 1 at October 31,
1999,  while  cash,  cash  equivalents  and  marketable   securities   comprised
$1,784,000.  This level of liquid  assets,  combined with budgeted cash flow, is
adequate to meet periodic needs.

CHANGE IN ACCOUNTING PRINCIPLE

The Company adopted SOP 98-5, REPORTING THE COSTS OF START-UP ACTIVITIES, in the
quarter ended October 31, 1999.  The Company was previously  deferring  start-up
costs associated with its California subsidiary.  The subsidiary will operate as
a Specialized  Knox-Keene  Health Care Services  Organization  upon approval and
licensure by the California Department of Corporations.

YEAR 2000

The  Company  formed a Year 2000  Task  Force  over two  years ago to  perform a
comprehensive review of its core business applications  (information  technology
("IT") and  non-IT).  The review was  performed  in  conjunction  with  planning
efforts to enhance  the  Company's  existing  infrastructure  and to support the
Company's  addition of full-benefit  insured and  self-funded  group vision care
products.  From this effort, a managed vision care software system was purchased
to support the new products and to replace the software  system utilized for the
vision care  savings  product.  In  addition,  other  information  systems  were
identified  for upgrade.  In no case was a system  replaced or purchased  solely
because of Year 2000  issues.  Thus,  the Company  does not believe the costs of
these software replacements are specifically Year 2000 related.

The Company tested and  implemented  improvements,  related to Year 2000 issues,
from its  software  vendors.  The  Company  believes it did not incur additional
material costs in the implementation of the improvements.

The  Company  also  worked  with  its  non-IT  systems   vendors.   Testing  and
implementation of these modifications is complete.

                                                                          Page 8
<PAGE>
The Company  continues to verify Year 2000  readiness of third parties  (vendors
and  customers)  with whom the Company has material  relationships.  The Company
will formulate a contingency plan if it identifies  vendors or customers that it
feels will not be compliant.  There can be no assurance that the Company will be
able to  completely  resolve all Year 2000 issues,  or that the ultimate cost to
identify and implement solutions to all Year 2000 issues will not be material.

                           PART II. OTHER INFORMATION

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Incorporated  by reference to the  Company's  1999  Definitive  Notice and Proxy
Statement Filed November 15, 1999.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

        (a) EXHIBITS

            27 -- Financial Data Schedule

        (b) REPORTS ON FORM 8-K

            No reports on Form 8-K have been filed  during the quarter for which
            this report is filed.


                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the registrant  caused
this  report to be  signed on its  behalf  by the  undersigned,  thereunto  duly
authorized.

FIRST AMERICAN HEALTH CONCEPTS, INC.
           (Registrant)


By:  /s/ John A. Raycraft
    -------------------------------------
    John A. Raycraft
    President and Chief Executive Officer


By: /s/ Margaret M. Eardley
    -------------------------------------
    Margaret M. Eardley
    Vice President of Finance and Chief
    Financial Officer


Date: December 15, 1999

                                                                          Page 9

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
CONSOLIDATED  FINANCIAL STATEMENTS FOR THE QUARTER ENDED OCTOBER 31, 1999 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-2000
<PERIOD-START>                             AUG-01-1999
<PERIOD-END>                               OCT-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                       1,553,810
<SECURITIES>                                   229,500
<RECEIVABLES>                                2,064,782
<ALLOWANCES>                                    40,385
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,736,322
<PP&E>                                       4,112,331
<DEPRECIATION>                               2,436,861
<TOTAL-ASSETS>                               6,411,792
<CURRENT-LIABILITIES>                        1,022,148
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       757,296
<OTHER-SE>                                   4,632,348
<TOTAL-LIABILITY-AND-EQUITY>                 6,411,792
<SALES>                                              0
<TOTAL-REVENUES>                             2,588,138
<CGS>                                                0
<TOTAL-COSTS>                                2,371,238
<OTHER-EXPENSES>                              (27,451)
<LOSS-PROVISION>                                 2,515
<INTEREST-EXPENSE>                                 448
<INCOME-PRETAX>                                243,903
<INCOME-TAX>                                    89,802
<INCOME-CONTINUING>                            154,101
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                    (727,259)
<NET-INCOME>                                 (573,158)
<EPS-BASIC>                                     (0.22)
<EPS-DILUTED>                                   (0.22)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission